Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_________________] (“Holder”), as registered owner of this Purchase Warrant, to Superconductor Technologies Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from November 26, 2013 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, November 25, 2016 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 100,000 shares of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. This Purchase Warrant is initially exercisable at $0.375 per Share (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Superconductor Technologies Inc)
Purchase Warrant. THIS CERTIFIES THAT, in In consideration of funds duly for a convertible note paid by or on behalf of [_________________] (“Holder”)to bioAffinity Technologies, as registered owner of this Purchase Warrant, to Superconductor Technologies Inc., a Delaware corporation Inc. (the “Company”), [NAME] or its assigns (“Holder”), have been issued this Purchase Warrant. Holder is entitled, at any time or from time to time from November 26[DATE], 2013 2022 (the “Commencement Date”), and at to or before 5:00 p.m., Eastern eastern time, November 25[DATE], 2016 2027 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 100,000 [NUMBER] shares (the “Shares”) of common stock of the Company, par value $0.001 per share (the “Shares”)share, subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant except as otherwise provided herein or with the Holder’s consent. This Purchase Warrant is initially exercisable at $0.375 per Share (125% of the price of the Shares sold in Company’s initial public offering (or $0.75 per Share if the OfferingCompany does not complete its initial public offering by May 31, 2022); provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.
Appears in 1 contract
Sources: Common Share Purchase Warrant (bioAffinity Technologies, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_________________] Aegis Capital Corp. (“Holder”), as registered owner of this Purchase Warrant, to Superconductor Technologies Oculus Innovative Sciences, Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from November 26March 12, 2013 2014 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, November 25March 12, 2016 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 100,000 [ ] shares of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate the Purchase Warrant. This Purchase Warrant is initially exercisable at $0.375 [ ] per Share ([125% of the price of the Shares sold in the Offering)]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Oculus Innovative Sciences, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_________________·] (“Holder”), as registered owner of this Purchase Warrant, to Superconductor Technologies Advaxis, Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from November 26[·], 2013 2014 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, November 25[·], 2016 2018 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 100,000 [·] shares of common stock of the CompanyCompany [equal to 3% of the Shares sold in the Offering], par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate the Purchase Warrant. This Purchase Warrant is initially exercisable at $0.375 [·] per Share (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.
Appears in 1 contract
Sources: Warrant Agreement (Advaxis, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_________________·] (“Holder”), as registered owner of this Purchase Warrant, to Superconductor Technologies A▇▇▇▇ Biosciences, Inc., a Delaware New Jersey corporation (the “Company”), Holder is entitled, at any time or from time to time from November 26[_________], 2013 2014 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, November 25[___________], 2016 2018 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 100,000 [·] shares of common stock of the CompanyCompany [equal to 3% of the Shares sold in the Offering], par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate the Purchase Warrant. This Purchase Warrant is initially exercisable at $0.375 [___] per Share (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_________________] _ (“Holder”), as registered owner of this Purchase Warrant, to Superconductor Technologies Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from November 26July 12, 2013 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, November 25July 12, 2016 2017 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 100,000 [ ] [3% of shares sold in offering excluding over-allotment] of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. This Purchase Warrant is initially exercisable at $0.375 4.0625 per Share (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Ampio Pharmaceuticals, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_________________·] (“Holder”), as registered owner of this Purchase Warrant, to Superconductor Technologies S▇▇▇▇▇ Scientific, Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from November 26[·], 2013 20[14] (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, November 25[·], 2016 20[18] (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to 100,000 [·] shares of common stock of the CompanyCompany [equal to 5% of the Shares sold in the Offering], par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate the Purchase Warrant. This Purchase Warrant is initially exercisable at $0.375 [·] per Share (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Semler Scientific, Inc.)